Corporate - CooperSurgical

CooperSurgical Launches Paragard® Intrauterine Copper Contraceptive with New Single-Hand Inserter

The simplified insertion process is a milestone innovation for the market’s leading hormone-free contraceptive, with an efficacy rate greater than…
CooperCompanies Acquires obp Surgical, Expanding CooperSurgical’s Portfolio of Leading Medical Devices

SAN RAMON, Calif., August 1, 2024 — CooperCompanies (Nasdaq: COO), today announced that CooperSurgical has acquired obp Surgical, a U.S.-based…
CooperSurgical has acquired ZyMōt Fertility

Sperm Separation Technology Adds to CooperSurgical’s Leading Fertility Products and Services. TRUMBULL, CONN., June 10, 2024 — CooperSurgical today announced that it has…
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

Testing offers CBR families the opportunity to proactively seek additional information about their child’s health TRUMBULL, Conn. and EL MONTE, Calif., Feb….
The Story Behind the Art: Our Watercolorist’s Journey to Motherhood

Throughout the new CooperSurgical.com website, you’ll see beautiful watercolor paintings that truly capture the essence of our mission. These vibrant, warm depictions of…
We’re In The News! #BladderHealth Awareness Month

We’re in the news! Did you know that November is #BladderHealth Awareness Month? National news program Daily Flash shared our…
Cord Blood Registry® Announces Thought Leadership Role at Cord Blood Connect

Marquee industry conference will showcase data from CBR’s Newborn Possibilities Program® TRUMBULL, Conn., Sept. 8, 2023 – CooperSurgical, a global leader in…
Chrissy Teigen Selects Cord Blood Registry® to Preserve Fourth Child’s Newborn Stem Cells

Banking newborn stem cells an option for couples choosing gestational carrier TRUMBULL, Conn., July 27, 2023 CooperSurgical, a global leader in…